These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3482458)

  • 1. [Cellular pathobiology of tumors in the mouth: metabolic, endocrine and immunologic interaction].
    Viti M; Barucchi AM; Mazza A; Iemmola G
    G Stomatol Ortognatodonzia; 1987; 6(1):3-10. PubMed ID: 3482458
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
    Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Defensins and tumor immunity and its relationship to oral tumors].
    Wang HY; Zhou ZT
    Shanghai Kou Qiang Yi Xue; 2004 Aug; 13(4):318-20. PubMed ID: 15349677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro changes in natural killer cell activity in draining lymph nodes of oral carcinomas].
    Vinzenz K; Strassl H; Micksche M
    Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(6):421-7. PubMed ID: 6085294
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cryoimmunology and tumors of the oral cavity].
    Fazio M; Canarutto P; Airoldi M; Negri L
    Minerva Stomatol; 1983; 32(6):783-9. PubMed ID: 6583476
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of immunologic parameters for preoperative prognostication in carcinoma of the mouth].
    Hyckel P; Metzner G; Müller P; Haroske D; Quade R
    Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(6):461-8. PubMed ID: 3869490
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of lymphocytes from patients with oral cancer to autochthonous tumour antigen.
    Gangal SG; Rao RS; Agashe SS; Nair PN; Ranadive KJ
    Indian J Med Res; 1973 Mar; 61(3):416-21. PubMed ID: 4756214
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of tumor-regression antigens in melanoma.
    Kawakami Y; Robbins PF; Wang RF; Rosenberg SA
    Important Adv Oncol; 1996; ():3-21. PubMed ID: 8791125
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of tumor markers in the diagnosis of oral tumors].
    Bienengräber V; Putzke HP
    Stomatol DDR; 1986 Aug; 36(8):448-53. PubMed ID: 3467481
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cell-mediated immunity in esophageal cancer patients--effect of "109" crude extracts on the cytotoxic effect of lymphocytes from esophageal cancer patients (author's transl)].
    Peng RL; Wang DB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Sep; 2(3):201-3. PubMed ID: 6451323
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of immunity in cancer.
    Baldwin RW
    Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
    [No Abstract]   [Full Text] [Related]  

  • 14. A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line.
    Lee BK; Kim MJ; Jang HS; Lee HR; Ahn KM; Lee JH; Choung PH; Kim MJ
    In Vivo; 2008; 22(5):593-7. PubMed ID: 18853752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
    Ravindranath NM; Nishimoto K; Chu K; Shuler C
    Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunology of tumors].
    Clerici E
    Minerva Nefrol; 1983; 30(2 Suppl):13-8. PubMed ID: 6866320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immune response to Epstein-Barr virus in patients with otorhinolaryngologic neoplasms of various morphology and invasiveness].
    Isaeva TM; Choĭnozonov EL; Podoplekin VD
    Vestn Otorinolaringol; 1994; (1):13-6. PubMed ID: 7785130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 19. Effector immune mechanisms in cancer.
    Lotzová E
    Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic relevance of histologic and immunologic parameters as a contribution to the data on individualized treatment plans for carcinoma of the mouth].
    Hyckel P; Metzner G; Müller P; Quade R
    Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(6):475-80. PubMed ID: 3869492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.